F9 and hemophilia B: In humans, FIX expression was attenuated in a patient with pre-existing NAb titer of 1:17 who was administered an AAV2 vector to treat hemophilia B.96In another study, which evaluated rAAV (Spark100) GTx in hemophilia B patients, George et al.